Laboratoire des Glucides - UMR CNRS 6219, Faculté de Pharmacie, rue des Louvels, Amienx Cedex 1, France.
Exp Parasitol. 2010 Jul;125(3):202-7. doi: 10.1016/j.exppara.2010.01.016. Epub 2010 Jan 28.
Compounds obtained by the condensation of ursolic acid (UA) with 1,4-bis(3-aminopropyl)piperazines have previously been shown as cytocidal to Plasmodium falciparum strains. Preliminary results indicated that the inhibition of beta-hematin formation (one of the possible mechanisms of action of antimalarial drugs) was achieved by a few of these molecules with varying efficiencies. To gain further insight in the antimalarial action of UA derivatives, we report here the results of additional pathways that may explain their in vitro cytocidal activity such as inhibition of hemin degradation by H(2)O(2) or glutathione (GSH). H(2)O(2)-mediated hemin degradation was drastically reduced by hydroxybenzyl-substituted UA derivatives while UA and intermediate compounds displayed weaker inhibitory actions. The results of GSH-mediated hemin degradation inhibition did not parallel those of H(2)O(2) degradation as hydroxybenzyl-substituted UA only proved to be a weak inhibitor. As H(2)O(2) interaction with the iron moiety of hemin is the first step towards its degradation, we assume that the interaction of our products with the ferric ion in the hemin structure is of upmost importance in inhibiting its peroxidative degradation. A two-step mechanism of action implying (1) stacking of the acetylursolic acid structure to hemin and (2) additive protection of hemin ferric iron from H(2)O(2) by hydroxyphenyl groups through steric hindrance and/or trapping of oxygen reactive species in the direct neighborhood of ferric iron can be put forward. For GSH degradation pathway, grafting of UA structure with a piperazine structure gave the best inhibition, pleading for the implication of this latter moiety in the inhibitory process.
熊果酸(UA)与 1,4-双(3-氨基丙基)哌嗪缩合得到的化合物以前被证明对恶性疟原虫株具有细胞毒性。初步结果表明,这些分子中的几种通过不同的效率抑制β-血红素形成(抗疟药物的一种可能作用机制)。为了更深入地了解 UA 衍生物的抗疟作用,我们在此报告了可能解释其体外细胞毒性活性的其他途径的结果,例如抑制血红素降解由 H(2)O(2)或谷胱甘肽(GSH)。H(2)O(2)介导的血红素降解被羟基苄基取代的 UA 衍生物大大降低,而 UA 和中间化合物显示出较弱的抑制作用。GSH 介导的血红素降解抑制的结果与 H(2)O(2)降解的结果不一致,因为羟基苄基取代的 UA 仅被证明是一种弱抑制剂。由于 H(2)O(2)与血红素的铁部分的相互作用是其降解的第一步,我们假设我们的产品与血红素结构中铁离子的相互作用对于抑制其过氧化物降解至关重要。作用机制的两步机制,包括(1)乙酰熊果酸结构与血红素的堆积,以及(2)通过空间位阻和/或在铁离子的直接邻近捕获氧活性物质,羟基苯基基团对血红素铁的加性保护,可以提出。对于 GSH 降解途径,UA 结构与哌嗪结构的嫁接给出了最佳的抑制作用,表明后一部分在抑制过程中的作用。